Oregon’s two senators, joined by six Democratic colleagues, are renewing their demand for medical marijuana research. They want more answers, solutions, and actions from obstructive federal agencies. The eight senators are incensed after the federal agencies to which they made inquiries failed to explain their inaction on cannabis research.
The Senators who are raising their voices for more medical marijuana action are:
Ron Wyden and Jeff Merkley, led by Elizabeth Warren (D-Mass.), and along with Barbara Mikulski (D-Md.), Barbara Boxer (D-Calif.), Kirsten Gillibrand (D-N.Y.), Edward J. Markey (D-Mass.), and Cory Booker (D-N.J.)
Medical marijuana has been called “a wonder drug” because of its low toxicity (there is no lethal dose) and high effectiveness in dozens of medical and health conditions.
Remarkably, cannabis is an antioxidant, anti-inflammatory, anti-glaucoma, anti-dementia, anti-diabetes, anti-depressant, and anti-tumor agent.
These overwhelming benefits are why the Senators are so furious that federal restrictions have allowed almost no study.
Even worse, the little research that was approved was directed by political correctness and “canna bigotry” to try to find adverse effects.
The action by these senators is a follow-up to Senate action last summer demanding that the agencies stop stalling cannabis research.
In July, the DEA administrator, ONDCP ‘drug czar’, and HHS head all received from these eight senators a request to work together to end the stifling medical marijuana research roadblocks.
Now, these bureaucrats just received fresh inquiries from the Senate due to the inadequate responses to the July request. Senator Warren wrote:
“There are currently numerous federal and state regulatory barriers to researching marijuana. This statutory scheme which limits medical marijuana research is outdated and in desperate need of serious and immediate review, and these problems exacerbate the lack of coordination between the agencies and states.”
The senators demanded action on several fronts
- The supply of marijuana for research purposes.
- Assessment of marijuana is rescheduling.
- Interagency coordination and research applications.
- Surveillance and epidemiological studies.
- Coordination with states and inter-agency cooperation.
Unfortunately, this Senate prodding of these obstructive bureaucracies was not bipartisan.
Surely, at least one Republican could sign on: Rand Paul. Paul, the Kentucky Republican is one of the Senate’s best regarding criminal justice reform and marijuana policy.
He is a cosponsor of the groundbreaking CARERS Act, which unfortunately stuck under the oppressive thumb of Senate Judiciary Chairman, Chuck Grassley.
Hopefully, this useful follow-up by eight leading, progressive senators should show these drug war bureaucrats that the time of delaying necessary marijuana policies is over.